{"id":"https://openalex.org/W4361869099","doi":"https://doi.org/10.1158/0008-5472.22371161","title":"Supplementary Figure 5 from MUC1 Oncoprotein Regulates Bcr-Abl Stability and Pathogenesis in Chronic Myelogenous Leukemia Cells","display_name":"Supplementary Figure 5 from MUC1 Oncoprotein Regulates Bcr-Abl Stability and Pathogenesis in Chronic Myelogenous Leukemia Cells","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361869099","doi":"https://doi.org/10.1158/0008-5472.22371161"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22371161","doi":"https://doi.org/10.1158/0008-5472.22371161","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22371161","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_MUC1_Oncoprotein_Regulates_Bcr-Abl_Stability_and_Pathogenesis_in_Chronic_Myelogenous_Leukemia_Cells/22371161/1/files/39816254.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_MUC1_Oncoprotein_Regulates_Bcr-Abl_Stability_and_Pathogenesis_in_Chronic_Myelogenous_Leukemia_Cells/22371161/1/files/39816254.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017473943","display_name":"Takeshi Kawano","orcid":"https://orcid.org/0000-0003-1535-9254","observed_orcids":["https://orcid.org/0000-0003-1535-9254"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takeshi Kawano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031134630","display_name":"Masaki A. Ito","orcid":"https://orcid.org/0000-0002-9635-9709","observed_orcids":["https://orcid.org/0000-0002-9635-9709"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masaki Ito","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032111744","display_name":"Deepak  Bushan Raina","orcid":"https://orcid.org/0000-0001-8767-892X","observed_orcids":["https://orcid.org/0000-0001-8767-892X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deepak Raina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100986988","display_name":"Zekui Wu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zekui Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054346063","display_name":"Jacalyn M. Rosenblatt","orcid":"https://orcid.org/0000-0001-5582-8161","observed_orcids":["https://orcid.org/0000-0001-5582-8161"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacalyn Rosenblatt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052641327","display_name":"David Avigan","orcid":"https://orcid.org/0000-0003-4624-6017","observed_orcids":["https://orcid.org/0000-0003-4624-6017"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Avigan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Stone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5067054634","display_name":"Donald W. Kufe","orcid":"https://orcid.org/0000-0001-5743-8888","observed_orcids":["https://orcid.org/0000-0001-5743-8888"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donald Kufe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.9089999794960022},{"id":"https://openalex.org/keywords/protein-stability","display_name":"protein stability","score":0.9810000061988831},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/leukemogenesis","display_name":"leukemogenesis","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.8942224979400635},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.7379991412162781},{"id":"https://openalex.org/C43907098","wikidata":"https://www.wikidata.org/wiki/Q903924","display_name":"breakpoint cluster region","level":3,"score":0.6385053396224976},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5391581058502197},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5164544582366943},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37449556589126587},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34773826599121094},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3379333019256592},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.23761290311813354},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1338721513748169}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.22371161","doi":"https://doi.org/10.1158/0008-5472.22371161","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22371161","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_MUC1_Oncoprotein_Regulates_Bcr-Abl_Stability_and_Pathogenesis_in_Chronic_Myelogenous_Leukemia_Cells/22371161/1/files/39816254.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22371161","doi":"https://doi.org/10.1158/0008-5472.22371161","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22371161","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_MUC1_Oncoprotein_Regulates_Bcr-Abl_Stability_and_Pathogenesis_in_Chronic_Myelogenous_Leukemia_Cells/22371161/1/files/39816254.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361869099.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392692476","https://openalex.org/W2136987415","https://openalex.org/W3013797470","https://openalex.org/W2138208598","https://openalex.org/W2550042150","https://openalex.org/W1946154114","https://openalex.org/W2036656143","https://openalex.org/W2943751469","https://openalex.org/W2943581852","https://openalex.org/W2318195134"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"5":[2],"from":[3],"MUC1":[4],"Oncoprotein":[5],"Regulates":[6],"Bcr-Abl":[7],"Stability":[8],"and":[9],"Pathogenesis":[10],"in":[11],"Chronic":[12],"Myelogenous":[13],"Leukemia":[14],"Cells":[15]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-04-05T00:00:00"}